Haemonetics (HAE) shares outstanding

Shares outstanding · fiscal 2026
47.35M

Haemonetics (HAE) had 47.35M diluted shares on average in fiscal 2026 (the year ended March 31, 2026). That is 6.7% lower than the 50.73M of fiscal 2025. Figures as of 18 Nov 2026, 11:57 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2026
47.35M
Change on fiscal 2025
−6.7%
Growth, 5 years
−1.6% a year
Growth, 10 years
−0.7% a year
Highest on record
53.50Mfiscal 2018
Lowest on record
47.35Mfiscal 2026
Fiscal years on record
182009–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Haemonetics shares outstanding, in more detail

The market data feed counts 45.54M shares outstanding today.

Over the five fiscal years to 2026 the diluted share count shrank at a compound 1.6% a year; over ten years the rate was −0.7% a year. Across the 18 fiscal years on record (2009–2026), the highest was 53.50M in fiscal 2018 and the lowest 47.35M in fiscal 2026.

History · 18 fiscal years

Shares outstanding by fiscal year

Haemonetics shares outstanding, year by year

Haemonetics (HAE) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202647.35M 6.7% down
202550.73M 1.3% down
202451.40M 0.0% down
202351.42M 0.1% up
202251.35M 0.1% up
202151.29M 1.0% down
202051.82M 2.1% down
201952.94M 1.0% down
201853.50M 3.8% up
201751.52M 1.2% up
201650.91M 2.3% down
201552.09M 0.5% down
201452.38M 0.2% up
201352.26M 1.3% up
201251.59M 0.8% up
201151.19M 1.8% down
201052.13M 0.4% down
200952.35M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Haemonetics and comparable companies
CompanyShares outstandingFiscal year
Hims & Hers Health HIMS258.23M2025
PTC Therapeutics PTCT88.31M2025
Haemonetics HAE47.35M2026
Erasca ERAS283.53M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on HAE

Haemonetics, figure by figure

Haemonetics (HAE) overview: price, valuation and scorecardAll health care companies by market value

Haemonetics shares outstanding: questions and answers

How many shares does Haemonetics have?

Haemonetics (HAE) had 47.35M diluted shares on average in fiscal 2026 (the year ended March 31, 2026). That is 6.7% lower than the 50.73M of fiscal 2025. The market data feed counts 45.54M shares outstanding today.

What is the growth rate of Haemonetics's diluted share count?

Over the five fiscal years to 2026 the diluted share count shrank at a compound 1.6% a year; over ten years the rate was −0.7% a year.

What are the highest and lowest diluted share count figures on record for Haemonetics?

Across the 18 fiscal years on record (2009–2026), the highest was 53.50M in fiscal 2018 and the lowest 47.35M in fiscal 2026.

How is Haemonetics's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Haemonetics it is on record here for 18 fiscal years, 2009 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Haemonetics (HAE) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/HAE/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.